☆ 4.5 Letter

Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia

BLOOD CANCER JOURNAL (2021)

Get Full Text
Add to Collection

Journal

BLOOD CANCER JOURNAL
Volume 11, Issue 2, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41408-021-00410-w

Keywords

-

Categories

Oncology Hematology

Funding

  1. ASCO Young Investigator Award from the Conquer Cancer Foundation
  2. MD Anderson Cancer Center from the National Cancer Institute [CA016672]
  3. National Institutes of Health [R01CA235622]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.